Topics

Cabaletta Bio nets $69.6mm via initial public offering

15:40 EDT 28 Oct 2019 | Elsevier Business Intelligence

Cabaletta Bio Inc. (cell therapies) netted $69.6mm through its initial public offering of 6.8mm common shares at $11. The com...

Original Article: Cabaletta Bio nets $69.6mm via initial public offering

NEXT ARTICLE

More From BioPortfolio on "Cabaletta Bio nets $69.6mm via initial public offering"

Quick Search